Related Experiment Video

Updated: Jul 15, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

[Spontaneous cure of pneumonia caused by Chlamydia pneumoniae]

N Miyashita1, Y Kubota, S Kawabata

  • 1Department of Medicine, Kawasaki Medical School.

Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases
|August 1, 1995
PubMed

Insights

This study reports a case of recurrent pneumonia caused by Chlamydia pneumoniae. Both episodes resolved spontaneously, highlighting the potential for self-resolution of C. pneumoniae pneumonia.

Area of Science:

  • Infectious Diseases
  • Respiratory Medicine
  • Microbiology

Background:

  • Pneumonia is a significant cause of morbidity and mortality worldwide.
  • Chlamydia pneumoniae is an important respiratory pathogen.
  • Recurrent pneumonia necessitates thorough etiological investigation.

Observation:

  • A 62-year-old male presented with two distinct episodes of pneumonia.
  • The first episode, in June 1994, showed elevated IgG titers against C. pneumoniae and resolved spontaneously.
  • The second episode, in December 1994, presented with infiltration and pleural effusion, responding to antibiotic therapy, with concurrent elevated C. pneumoniae IgG titers suggesting mixed infection.

Findings:

  • Micro-immunofluorescence testing confirmed elevated IgG antibodies against Chlamydia pneumoniae in both episodes.
  • The initial episode resolved without treatment, indicating a spontaneous cure.
  • The second episode, while treated with carbapenem, also demonstrated characteristics of C. pneumoniae infection, potentially with a bacterial co-infection.

Implications:

  • This case underscores the possibility of spontaneous resolution in C. pneumoniae pneumonia.
  • It highlights the importance of considering atypical pathogens like C. pneumoniae in recurrent pneumonia.
  • Further research into the host-pathogen interactions and immune responses in C. pneumoniae infections is warranted.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...